Table 4 Clinical and pathologic characteristics between the two groups according to the Ki67 expression intensity
From: The clinicopathological significance of Ki67 in papillary thyroid carcinoma: a suitable indicator?
Characteristic | Group 1 (Ki67 < 2.5%) n = 300 | Group 2 (Ki67 ≥ 2.5%) n = 271 | P value | |
|---|---|---|---|---|
T Stage | T1 | 191 | 108 | < 0.001 |
T2 | 48 | 59 | ||
T3 | 62 | 99 | ||
T4 | 0 | 5 | ||
TNM Staging | Stage I | 172 | 111 | < 0.001 |
Stage II | 23 | 36 | ||
Stage III | 105 | 119 | ||
Stage IV | 0 | 5 | ||
Recurrence | Yes | 1 | 6 | 0.042 |
No | 299 | 265 | ||
Mortality | Yes | 0 | 1 | 0.293 |
No | 300 | 270 |